300 related articles for article (PubMed ID: 12003708)
1. Functional tests for primary aldosteronism: value of captopril suppression.
Racine MC; Douville P; Lebel M
Curr Hypertens Rep; 2002 Jun; 4(3):245-9. PubMed ID: 12003708
[TBL] [Abstract][Full Text] [Related]
2. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
4. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
5. Captopril suppression versus salt loading in confirming primary aldosteronism.
Agharazii M; Douville P; Grose JH; Lebel M
Hypertension; 2001 Jun; 37(6):1440-3. PubMed ID: 11408392
[TBL] [Abstract][Full Text] [Related]
6. Single dose captopril as a diagnostic test for primary aldosteronism.
Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
[TBL] [Abstract][Full Text] [Related]
7. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
8. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
[TBL] [Abstract][Full Text] [Related]
9. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study.
Tezuka Y; Omata K; Ono Y; Kambara K; Kamada H; Oguro S; Yamazaki Y; Gomez-Sanchez CE; Ito A; Sasano H; Takase K; Tanaka T; Katagiri H; Satoh F
Hypertens Res; 2024 May; 47(5):1362-1371. PubMed ID: 38454147
[TBL] [Abstract][Full Text] [Related]
10. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Reznik Y; Amar L; Tabarin A
Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
[TBL] [Abstract][Full Text] [Related]
11. Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
Vorselaars WMCM; Valk GD; Vriens MR; Westerink J; Spiering W
J Hypertens; 2018 Jul; 36(7):1585-1591. PubMed ID: 29528872
[TBL] [Abstract][Full Text] [Related]
12. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.
Montori VM; Young WF
Endocrinol Metab Clin North Am; 2002 Sep; 31(3):619-32, xi. PubMed ID: 12227124
[TBL] [Abstract][Full Text] [Related]
13. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
14. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
15. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
16. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.
Tsiavos V; Markou A; Papanastasiou L; Kounadi T; Androulakis II; Voulgaris N; Zachaki A; Kassi E; Kaltsas G; Chrousos GP; Piaditis GP
Eur J Endocrinol; 2016 Jul; 175(1):21-8. PubMed ID: 27072145
[TBL] [Abstract][Full Text] [Related]
17. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
18. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
20. [Detection of primary aldosteronism using the captopril test].
Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
